141 related articles for article (PubMed ID: 19356220)
21. Elevated expression of valosin-containing protein (p97) in hepatocellular carcinoma is correlated with increased incidence of tumor recurrence.
Yamamoto S; Tomita Y; Nakamori S; Hoshida Y; Nagano H; Dono K; Umeshita K; Sakon M; Monden M; Aozasa K
J Clin Oncol; 2003 Feb; 21(3):447-52. PubMed ID: 12560433
[TBL] [Abstract][Full Text] [Related]
22. FOXD1 Promotes Cell Growth and Metastasis by Activation of Vimentin in NSCLC.
Li D; Fan S; Yu F; Zhu X; Song Y; Ye M; Fan L; Lv Z
Cell Physiol Biochem; 2018; 51(6):2716-2731. PubMed ID: 30562753
[TBL] [Abstract][Full Text] [Related]
23. Cytoplasmic Kaiso is associated with poor prognosis in non-small cell lung cancer.
Dai SD; Wang Y; Miao Y; Zhao Y; Zhang Y; Jiang GY; Zhang PX; Yang ZQ; Wang EH
BMC Cancer; 2009 Jun; 9():178. PubMed ID: 19508730
[TBL] [Abstract][Full Text] [Related]
24. Elevated expression of valosin-containing protein (p97) is associated with poor prognosis of prostate cancer.
Tsujimoto Y; Tomita Y; Hoshida Y; Kono T; Oka T; Yamamoto S; Nonomura N; Okuyama A; Aozasa K
Clin Cancer Res; 2004 May; 10(9):3007-12. PubMed ID: 15131036
[TBL] [Abstract][Full Text] [Related]
25. The long non-coding RNA HOTAIR indicates a poor prognosis and promotes metastasis in non-small cell lung cancer.
Liu XH; Liu ZL; Sun M; Liu J; Wang ZX; De W
BMC Cancer; 2013 Oct; 13():464. PubMed ID: 24103700
[TBL] [Abstract][Full Text] [Related]
26. The differentiation/retrodifferentiation program of human U937 leukemia cells is accompanied by changes of VCP/p97.
Bertram C; von Neuhoff N; Skawran B; Steinemann D; Schlegelberger B; Hass R
BMC Cell Biol; 2008 Feb; 9():12. PubMed ID: 18279508
[TBL] [Abstract][Full Text] [Related]
27. Interferon regulatory factor 4 (IRF4) is overexpressed in human non‑small cell lung cancer (NSCLC) and activates the Notch signaling pathway.
Qian Y; Du Z; Xing Y; Zhou T; Chen T; Shi M
Mol Med Rep; 2017 Nov; 16(5):6034-6040. PubMed ID: 28849037
[TBL] [Abstract][Full Text] [Related]
28. Expression level of valosin-containing protein (p97) is associated with prognosis of esophageal carcinoma.
Yamamoto S; Tomita Y; Hoshida Y; Iizuka N; Kidogami S; Miyata H; Takiguchi S; Fujiwara Y; Yasuda T; Yano M; Nakamori S; Sakon M; Monden M; Aozasa K
Clin Cancer Res; 2004 Aug; 10(16):5558-65. PubMed ID: 15328197
[TBL] [Abstract][Full Text] [Related]
29. Krüppel-Like Factor 6 Downregulation Is Connected with a Poor Prognosis and Tumor Growth in Non-Small-Cell Lung Cancer.
Zeng B; Lin J; Cai X; Che L; Zeng W; Liu S
Comput Math Methods Med; 2022; 2022():3193553. PubMed ID: 35136416
[TBL] [Abstract][Full Text] [Related]
30. LATS2 as a poor prognostic marker regulates non-small cell lung cancer invasion by modulating MMPs expression.
Wu A; Li J; Wu K; Mo Y; Luo Y; Ye H; Mai Z; Guo K; Wang Y; Li S; Chen H; Luo W; Yang Z
Biomed Pharmacother; 2016 Aug; 82():290-7. PubMed ID: 27470365
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA‑1915‑3p prevents the apoptosis of lung cancer cells by downregulating DRG2 and PBX2.
Xu C; Li H; Zhang L; Jia T; Duan L; Lu C
Mol Med Rep; 2016 Jan; 13(1):505-12. PubMed ID: 26572100
[TBL] [Abstract][Full Text] [Related]
33. Over-expression of LSD1 promotes proliferation, migration and invasion in non-small cell lung cancer.
Lv T; Yuan D; Miao X; Lv Y; Zhan P; Shen X; Song Y
PLoS One; 2012; 7(4):e35065. PubMed ID: 22493729
[TBL] [Abstract][Full Text] [Related]
34. Differential expression of RBM5, EGFR and KRAS mRNA and protein in non-small cell lung cancer tissues.
Liang H; Zhang J; Shao C; Zhao L; Xu W; Sutherland LC; Wang K
J Exp Clin Cancer Res; 2012 Apr; 31(1):36. PubMed ID: 22537942
[TBL] [Abstract][Full Text] [Related]
35. Dendrimer-Based Selective Proteostasis-Inhibition Strategy to Control NSCLC Growth and Progression.
Walworth K; Bodas M; Campbell RJ; Swanson D; Sharma A; Vij N
PLoS One; 2016; 11(7):e0158507. PubMed ID: 27434122
[TBL] [Abstract][Full Text] [Related]
36. Decreased microRNA-224 and its clinical significance in non-small cell lung cancer patients.
Zhu D; Chen H; Yang X; Chen W; Wang L; Xu J; Yu L
Diagn Pathol; 2014 Nov; 9():198. PubMed ID: 25410592
[TBL] [Abstract][Full Text] [Related]
37. Copper-transporting P-type adenosine triphosphatase (ATP7A) is associated with platinum-resistance in non-small cell lung cancer (NSCLC).
Li ZH; Qiu MZ; Zeng ZL; Luo HY; Wu WJ; Wang F; Wang ZQ; Zhang DS; Li YH; Xu RH
J Transl Med; 2012 Feb; 10():21. PubMed ID: 22304828
[TBL] [Abstract][Full Text] [Related]
38. Expression of PHF20 protein contributes to good prognosis of NSCLC and is associated with Bax expression.
Tang N; Ma L; Lin XY; Zhang Y; Yang DL; Wang EH; Qiu XS
Int J Clin Exp Pathol; 2015; 8(10):12198-206. PubMed ID: 26722404
[TBL] [Abstract][Full Text] [Related]
39. Down-regulation of hepatoma-derived growth factor inhibits anchorage-independent growth and invasion of non-small cell lung cancer cells.
Zhang J; Ren H; Yuan P; Lang W; Zhang L; Mao L
Cancer Res; 2006 Jan; 66(1):18-23. PubMed ID: 16397209
[TBL] [Abstract][Full Text] [Related]
40. MKL1-induced lncRNA SNHG18 drives the growth and metastasis of non-small cell lung cancer via the miR-211-5p/BRD4 axis.
Fan H; Yuan J; Li Y; Jia Y; Li J; Wang X; Li X
Cell Death Dis; 2021 Jan; 12(1):128. PubMed ID: 33500406
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
